Chris Sander, formerly head of the scientific informatics division at Millennium Pharmaceuticals, has left the company.A source close to the company said that Sander left the company back in July due to “differences of opinion.”Sander, who is also a visiting scientist at the Whitehead Institute for Biomedical Research, did not return a call seeking comment.Millennium has not decided whether it would find a replacement for Sander.In the meantime, all of the scientific informatics directors who previously reported to Sander are now reporting to Michael Pavia, the company’s chief technology officer.
David Wang, formerly head of genomics and bioinformatics at Motorola, Andrea Califano, previously director of IBM’s Computational Biology Center, and Arthur Holden, chairman and CEO of the SNP Consortium, have teamed up to establish the First Genetic Trust, a new company that will serve as a genetic bank. The company, which will be based in Chicago, will hold accounts containing individual genetic profiles and act as an intermediary between patients, researchers, and healthcare providers. The company will collect, analyze, and maintain genetic data for ongoing clinical trials for drug discovery. The company will also host an online portal for genetic information, education, and counseling services. As genetic medicine becomes more prevalent in the diagnosis and treatment of major diseases, First Genetic Trust will expand its services to include online genetic banking. Holden will be the chairman and CEO of the new venture.
Blackstone Technology Group of Worcester, Mass., has hired Rebecca Hyman as vice president of technology. Before joining the compute farm services provider Hyman was information technology manager of international software development at Syncor International, a provider of radiopharmaceuticals.